PEPperPRINT GmbH

"Whether you're discovering new epitopes, optimizing therapeutics, or validating specificity, get the complete picture of every binding event with laser-printed peptide microarrays."

Where it wins

• Unrivaled throughput and resolution for both linear and conformational epitopes compared to shotgun mutagenesis or X-ray crystallography [1].
• Proprietary laser-based peptide synthesis platform (cLIFT) allows for high-density, user-defined custom arrays with short turnaround times [1][2].
• ISO9001-certified processes ensure reproducible results and transparent documentation for rigorous diagnostic and therapeutic development [1].
• Fully integrated service option (PEPperMAP®) provides data read-out and evaluation without requiring in-house lab infrastructure [2].

Credibility: PEPperPRINT homepage details the PEPperCHIP® technology advantages and ISO9001 certification, while Growjo confirms the proprietary laser printing technology and service portfolio [1][2].

• Technology Licensing & Sales: Sells proprietary laser-printed peptide microarrays that scale through high-throughput manufacturing [1].
• Service-Based Revenue: Offers PEPperMAP® services to clients lacking lab infrastructure, converting scientific expertise into a scalable service [2].
• Unit of Value: Delivers high-resolution epitope mapping data and antibody specificity insights to accelerate drug discovery and diagnostics [1].
• Margin Driver: High-margin custom arrays and services leverage proprietary cLIFT technology, reducing manual synthesis costs [1][2].

• Mersive: Competes in the broader biotech tools space, but lacks PEPperPRINT's specialized epitope mapping focus [2].
• Quantum Metric: Operates in a different sector (digital experience analytics), not a direct competitor [2].
• Intellectyx: Focuses on data analytics, not peptide microarrays or epitope mapping [2].
• Differentiators: PEPperPRINT's proprietary laser printing technology, ISO9001 certification, and comprehensive service offering provide a distinct advantage in epitope mapping and antibody research [1][2].

• Low Throughput in Epitope Mapping: Traditional methods like X-ray crystallography are slow and low-throughput [1].
• Inability to Map Conformational Epitopes: Many techniques fail to capture conformational epitopes, limiting antibody characterization [1].
• High Cost and Complexity: Deep mutational scanning and HDX-MS are expensive and require specialized infrastructure [1].
• Lack of Customization: Standard peptide libraries lack the flexibility for user-defined experimental needs [2].

PEPperPRINT's proprietary laser printing technology and ISO9001 certification create a strong moat in the epitope mapping market. The main risk is the potential for new competitors to replicate the cLIFT platform. The opportunity lies in expanding into therapeutic antibody development and diagnostic markets. The next signal to watch is the adoption rate of PEPperMAP® services among pharma companies.

Expand marketing efforts to highlight the cost-effectiveness of PEPperCHIP® compared to traditional methods. Develop case studies showcasing successful collaborations with biotech and pharma companies. Explore partnerships with diagnostic firms to integrate PEPperPRINT technology into their workflows. Offer training programs to enhance customer adoption and proficiency with the technology.